Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

FATE

Fate Therapeutics, Inc.

Healthcare · USD

Set alert

Price alert · FATE

All alert types
2.08 USD -0.09 -4.15%
As of Oct 30, 2026 Extended hours 2.08 0.00%
Bid
2.08 × 2
Ask
2.09 × 2
2.01 Day range 2.16
0.96 52-week range 3.11
YTD
+112.24%
1 year
+61.24%
Open
2.13
Prev close
2.17
Mkt cap
249.23M
Vol
1.06M
Avg vol
1.58M
EPS
-1.05
P/E
0.00
Div yield
0.00%
More statistics
Low
2.01
High
2.16
Forward P/E
-0.99
Beta
1.88
Short ratio
3.10
Inst. own
102.25%
Dividend
0.00
Ex-div date
50-d avg
2.53
200-d avg
3.93
1y target
6.31

5D chart

Chart tools
Interval
1m5m15m30m
FATE five-day price chart2.022.072.132.182.23Oct 23Oct 26Oct 27Oct 28Oct 29

Financial health

Altman Z-Score

-8.24 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 3

Valuation

P/E -0.9×
FY 2016: -2.4×FY 2017: -6.0×FY 2018: -10.8×FY 2019: -13.7×FY 2020: -43.3×FY 2021: -26.1×FY 2022: -3.5×FY 2023: -2.3×FY 2024: -1.0×FY 2025: -0.9×
FY 2016 5y median -2.3× FY 2025
P/S 17.6×
FY 2016: 18.1×FY 2017: 62.5×FY 2018: 152×FY 2019: 125×FY 2020: 238×FY 2021: 99.3×FY 2022: 10.1×FY 2023: 5.8×FY 2024: 13.8×FY 2025: 17.6×
FY 2016 5y median 13.8× FY 2025
P/B 0.6×
FY 2016: 1.1×FY 2017: 3.3×FY 2018: 4.5×FY 2019: 5.5×FY 2020: 19.5×FY 2021: 8.2×FY 2022: 2.0×FY 2023: 1.0×FY 2024: 0.6×FY 2025: 0.6×
FY 2016 5y median 1.0× FY 2025
P/FCF -1.0×
FY 2016: -2.6×FY 2017: -6.6×FY 2018: -17.6×FY 2019: -14.7×FY 2020: -170×FY 2021: -26.0×FY 2022: -3.4×FY 2023: -2.7×FY 2024: -1.5×FY 2025: -1.0×
FY 2016 5y median -2.7× FY 2025
EV/EBITDA -1.2×
FY 2016: -0.1×FY 2017: -4.5×FY 2018: -8.6×FY 2019: -13.4×FY 2020: -59.4×FY 2021: -26.8×FY 2022: -3.8×FY 2023: -3.0×FY 2024: -1.3×FY 2025: -1.2×
FY 2016 5y median -3.0× FY 2025
EV/Sales 22.3×
FY 2016: 0.4×FY 2017: 44.4×FY 2018: 115×FY 2019: 118×FY 2020: 236×FY 2021: 98.9×FY 2022: 10.6×FY 2023: 6.8×FY 2024: 17.4×FY 2025: 22.3×
FY 2016 5y median 17.4× FY 2025
FCF Yield -96.0%
FY 2016: -38.0%FY 2017: -15.1%FY 2018: -5.7%FY 2019: -6.8%FY 2020: -0.6%FY 2021: -3.9%FY 2022: -29.0%FY 2023: -37.6%FY 2024: -65.9%FY 2025: -96.0%
FY 2016 5y median -37.6% FY 2025

Profitability

Gross Margin -94.1%
FY 2016: -500.9%FY 2017: -736.8%FY 2018: -1081.9%FY 2019: 100.0%FY 2020: -299.6%FY 2021: 89.5%FY 2022: 85.7%FY 2023: -147.4%FY 2024: -769.6%FY 2025: -94.1%
FY 2016 5y median -94.1% FY 2025
Operating Margin -2222.4%
FY 2016: -726.1%FY 2017: -1025.9%FY 2018: -1415.4%FY 2019: -943.1%FY 2020: -407.5%FY 2021: -388.6%FY 2022: -320.2%FY 2023: -299.9%FY 2024: -1542.6%FY 2025: -2222.4%
FY 2016 5y median -388.6% FY 2025
Net Margin -2051.1%
FY 2016: -760.2%FY 2017: -1046.1%FY 2018: -1405.0%FY 2019: -919.0%FY 2020: -551.6%FY 2021: -379.9%FY 2022: -292.5%FY 2023: -253.3%FY 2024: -1366.5%FY 2025: -2051.1%
FY 2016 5y median -379.9% FY 2025
ROE -65.8%
FY 2016: -45.7%FY 2017: -55.6%FY 2018: -41.5%FY 2019: -40.1%FY 2020: -45.1%FY 2021: -31.3%FY 2022: -58.2%FY 2023: -43.7%FY 2024: -58.4%FY 2025: -65.8%
FY 2016 5y median -58.2% FY 2025
ROIC -51.4%
FY 2016: -36.3%FY 2017: -44.7%FY 2018: -35.6%FY 2019: -36.5%FY 2020: -23.7%FY 2021: -25.7%FY 2022: -51.6%FY 2023: -40.3%FY 2024: -51.3%FY 2025: -51.4%
FY 2016 5y median -51.3% FY 2025
ROA -42.7%
FY 2016: -35.2%FY 2017: -40.8%FY 2018: -31.3%FY 2019: -32.5%FY 2020: -27.9%FY 2021: -23.0%FY 2022: -39.9%FY 2023: -31.8%FY 2024: -42.3%FY 2025: -42.7%
FY 2016 5y median -39.9% FY 2025

Growth (YoY)

Revenue -51.2%
FY 2016: 81.1%FY 2017: -6.7%FY 2018: 15.4%FY 2019: 125.3%FY 2020: 194.3%FY 2021: 77.7%FY 2022: 72.4%FY 2023: -34.0%FY 2024: -78.5%FY 2025: -51.2%
FY 2016 FY 2025
Operating Income 29.8%
FY 2016: -15.0%FY 2017: -31.8%FY 2018: -59.3%FY 2019: -50.1%FY 2020: -27.2%FY 2021: -69.4%FY 2022: -42.1%FY 2023: 38.2%FY 2024: -10.4%FY 2025: 29.8%
FY 2016 FY 2025
EPS (diluted) 29.9%
FY 2016: 11.0%FY 2017: 2.9%FY 2018: -16.7%FY 2019: -20.2%FY 2020: -46.9%FY 2021: -6.7%FY 2022: -29.9%FY 2023: 43.6%FY 2024: 0.0%FY 2025: 29.9%
FY 2016 FY 2025
Free Cash Flow 9.4%
FY 2016: -52.2%FY 2017: -27.6%FY 2018: -6.0%FY 2019: -121.2%FY 2020: 51.2%FY 2021: -383.6%FY 2022: -32.9%FY 2023: 51.2%FY 2024: 10.7%FY 2025: 9.4%
FY 2016 FY 2025

Financial Health

Current Ratio 5.8×
FY 2016: 6.1×FY 2017: 9.3×FY 2018: 7.5×FY 2019: 8.2×FY 2020: 5.8×FY 2021: 7.8×FY 2022: 4.4×FY 2023: 8.5×FY 2024: 7.6×FY 2025: 5.8×
FY 2016 5y median 7.6× FY 2025
Quick Ratio 5.8×
FY 2016: 6.1×FY 2017: 9.3×FY 2018: 7.5×FY 2019: 8.2×FY 2020: 5.8×FY 2021: 7.8×FY 2022: 4.4×FY 2023: 8.5×FY 2024: 7.6×FY 2025: 5.8×
FY 2016 5y median 7.6× FY 2025
Debt / Equity 0.4×
FY 2016: 0.1×FY 2017: 0.2×FY 2018: 0.1×FY 2019: 0.1×FY 2020: 0.3×FY 2021: 0.2×FY 2022: 0.2×FY 2023: 0.3×FY 2024: 0.3×FY 2025: 0.4×
FY 2016 5y median 0.3× FY 2025
Net Debt / EBITDA -0.2×
FY 2016: 2.5×FY 2017: 1.8×FY 2018: 2.8×FY 2019: 0.8×FY 2020: 0.6×FY 2021: 0.1×FY 2022: -0.2×FY 2023: -0.4×FY 2024: -0.3×FY 2025: -0.2×
FY 2016 5y median -0.2× FY 2025
Interest Coverage 0.0×
FY 2016: -19.5×FY 2017: -33.2×FY 2018: -39.6×FY 2019: -57.5×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31